Federal regulators this week rejected a request to sell a morning-after birth-control pill without a prescription. The drug, Plan B, can prevent ovulation or keep a fertilized egg from implanting if taken within 72 hours of sex. The Food and Drug Administration said drug maker Barr Pharmaceuticals had failed to prove girls could safely use Plan B without a doctor’s help. Conservative activist Wendy Wright praised the ruling, saying the drug was too potent to be sold “next to candy bars and toothpaste.” But birth-control advocate Kirsten Moore said the decision denied women “a safe, proven second chance to prevent pregnancy.”
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
What does a slowdown in payroll additions mean for the coming year?
Today's Big Question New private payrolls were well below expectations this November, according to one report
By Justin Klawans, The Week US Published
Sen. Warren's food fight over a potential 'big sandwich' monopoly
Talking Point A private equity firm's attempted Subway takeover has federal regulators salivating.
By Rafi Schwartz, The Week US Published
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published